Is a complete NEO research report available?

No complete published report is available for NeoGenomics, Inc. (NEO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

NeoGenomics, Inc. (NEO)

NASDAQ: NEO · USD

$18.0

+0.71 (+4.1%)· Recorded snapshot

Market cap	2.3B
Revenue (ttm)	766.3M
Net income (ttm)	-51.9M
EPS (ttm)	-$0.40
Shares out	128.5M
P/E (forward)	64.0x
Volume	1,909,960
Beta	1.78

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 766.3M
Net income (ttm): -51.9M
EPS (ttm): -$0.40
P/E (forward): 64.0x
Market cap: 2.3B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Metric	Value
Amount currency	USD
CIK code	0001077183
Company name	NeoGenomics, Inc.
Country	United States
Country code	US
CUSIP number	64049M209
Earnings date	2026-10-28
Earnings time	amc
Employees	2,500
Employees change	300
Employees growth	13.64%
Enterprise value	$2.6B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2001
In index	RUSSELL2000
Industry	Diagnostics & Research
IPO date	1999-11-02
Is primary listing	Yes
Is SPAC	No
ISIN number	US64049M2098
Last 10-K release date	2026-02-17
Last earnings date	2026-10-28
Last refreshed	2026-10-28
Last stock split date	2003-04-16
Last stock split type	Reverse
Market cap	$2.3B
Market cap category	Mid-Cap
Next earnings date	2027-02-16
Options	Yes
Price	$17.98
Price currency	USD
Sector	Healthcare
SIC code	8734
Stock price date	2026-10-28
Symbol	NEO
U.S. state	Florida
Website	https://www.neogenomics.com

Metric

Value

Amount currency

USD

CIK code

0001077183

Company name

NeoGenomics, Inc.

Country

United States

Country code

CUSIP number

64049M209

Earnings date

2026-10-28

Earnings time

amc

Employees

2,500

Employees change

300

Employees growth

13.64%

Enterprise value

$2.6B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2001

In index

RUSSELL2000

Industry

Diagnostics & Research

IPO date

1999-11-02

Is primary listing

Yes

Is SPAC

ISIN number

US64049M2098

Last 10-K release date

2026-02-17

Last earnings date

2026-10-28

Last refreshed

2026-10-28

Last stock split date

2003-04-16

Last stock split type

Reverse

Market cap

$2.3B

Market cap category

Mid-Cap

Next earnings date

2027-02-16

Options

Yes

Price

$17.98

Price currency

USD

Sector

Healthcare

SIC code

8734

Stock price date

2026-10-28

Symbol

NEO

U.S. state

Florida

Website

https://www.neogenomics.com

Metric	Value
Adjusted P/E ratio	119.87x
Earnings yield	-2.24%
EV/EBITDA	107.41x
EV/Sales	3.41x
FCF / EV yield	-0.28%
FCF yield	-0.32%
Forward EV/Sales	3.09x
Forward P/E	63.99x
Forward P/S	2.73x
Industry forward P/E	30.87x
Industry P/E	50.24x
P/B ratio	2.81x
P/OCF ratio	104.77x
P/S ratio	3.01x
PEG ratio	1.21x
Price/EBITDA ratio	94.96x
Sector forward P/E	23.64x
Sector P/E	50.33x

Metric

Value

Adjusted P/E ratio

119.87x

Earnings yield

-2.24%

EV/EBITDA

107.41x

EV/Sales

3.41x

FCF / EV yield

-0.28%

FCF yield

-0.32%

Forward EV/Sales

3.09x

Forward P/E

63.99x

Forward P/S

2.73x

Industry forward P/E

30.87x

Industry P/E

50.24x

P/B ratio

2.81x

P/OCF ratio

104.77x

P/S ratio

3.01x

PEG ratio

1.21x

Price/EBITDA ratio

94.96x

Sector forward P/E

23.64x

Sector P/E

50.33x

Metric	Value
EBIT margin	-5.41%
EBITDA margin	3.17%
Gross margin	43.92%
Operating margin	-5.41%
Pretax margin	-7.12%
Profit margin	-6.77%
Profit per employee	$-20,751
Profitable quarters	1
Revenue per employee	$306,518
ROA	-1.89%
ROA (5Y)	-3.92%
ROCE	-3.33%
ROE	-6.33%
ROE (5Y)	-8.93%
ROIC	-3.8%
ROIC (5Y)	-9.38%
SBC / revenue	4.72%
Tax / revenue	-0.35%

Metric

Value

EBIT margin

-5.41%

EBITDA margin

3.17%

Gross margin

43.92%

Operating margin

-5.41%

Pretax margin

-7.12%

Profit margin

-6.77%

Profit per employee

$-20,751

Profitable quarters

Revenue per employee

$306,518

ROA

-1.89%

ROA (5Y)

-3.92%

ROCE

-3.33%

ROE

-6.33%

ROE (5Y)

-8.93%

ROIC

-3.8%

ROIC (5Y)

-9.38%

SBC / revenue

4.72%

Tax / revenue

-0.35%

Metric	Value
EPS growth quarters	3
EPS growth years	0
FCF growth (Q)	-16.19%
Gross profit growth	11.35%
Gross profit growth (Q)	19.54%
Gross profit growth 3Y	15.15%
Gross profit growth 5Y	9.75%
Net income growth quarters	3
Net income growth years	0
OCF growth	56.94%
OCF growth (Q)	-1.83%
OCF growth 10Y	2.88%
OCF growth 5Y	24.64%
Revenue growth	11.19%
Revenue growth (Q)	11.21%
Revenue growth (QoQ)	8.03%
Revenue growth 10Y	15.9%
Revenue growth 3Y	11.58%
Revenue growth 5Y	9.41%
Revenue growth quarters	18
Revenue growth years	24

Metric

Value

EPS growth quarters

EPS growth years

FCF growth (Q)

-16.19%

Gross profit growth

11.35%

Gross profit growth (Q)

19.54%

Gross profit growth 3Y

15.15%

Gross profit growth 5Y

9.75%

Net income growth quarters

Net income growth years

OCF growth

56.94%

OCF growth (Q)

-1.83%

OCF growth 10Y

2.88%

OCF growth 5Y

24.64%

Revenue growth

11.19%

Revenue growth (Q)

11.21%

Revenue growth (QoQ)

8.03%

Revenue growth 10Y

15.9%

Revenue growth 3Y

11.58%

Revenue growth 5Y

9.41%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-29.4M
Depreciation and amortization	$65.8M
EBIT	$-41.4M
EBITDA	$24.3M
EPS	$-0.40
FCF per share	$-0.06
Financing cash flow	$-11.4M
Free cash flow	$-7.4M
Free cash flow minus SBC	$-43.6M
Gross profit	$336.5M
Income taxes	$-2.7M
Investing cash flow	$-19.9M
Net borrowing	$41.2M
Net cash flow	$-9.2M
Net income	$-51.9M
Operating cash flow minus SBC	$-14.2M
Operating income	$-41.4M
Revenue	$766.3M
Stock-based compensation	$36.2M

Metric

Value

Capital expenditures

$-29.4M

Depreciation and amortization

$65.8M

EBIT

$-41.4M

EBITDA

$24.3M

EPS

$-0.40

FCF per share

$-0.06

Financing cash flow

$-11.4M

Free cash flow

$-7.4M

Free cash flow minus SBC

$-43.6M

Gross profit

$336.5M

Income taxes

$-2.7M

Investing cash flow

$-19.9M

Net borrowing

$41.2M

Net cash flow

$-9.2M

Net income

$-51.9M

Operating cash flow minus SBC

$-14.2M

Operating income

$-41.4M

Revenue

$766.3M

Stock-based compensation

$36.2M

Metric	Value
Altman Z-Score	1.55
Book value per share	$6.14
Debt / EBITDA	13.68
Debt / equity	0.57
Goodwill	$524M
Interest coverage	-16.06
Long-term assets	$970.8M
Long-term liabilities	$460.6M
Net cash (debt)	$-302.8M
Net cash / market cap	-13.11%
Net debt / EBITDA	12.45
Net debt / equity	0.39
Piotroski F-Score	4
Property, plant and equipment	$166.2M
Shareholders' equity	$785.7M
Tangible book value	$-9.5M
Tangible book value per share	$-0.07
Total assets	$1.4B
Total cash	$145.5M
Total debt	$448.4M
Total liabilities	$566.5M
WACC	11.85%

Metric

Value

Altman Z-Score

1.55

Book value per share

$6.14

Debt / EBITDA

13.68

Debt / equity

0.57

Goodwill

$524M

Interest coverage

-16.06

Long-term assets

$970.8M

Long-term liabilities

$460.6M

Net cash (debt)

$-302.8M

Net cash / market cap

-13.11%

Net debt / EBITDA

12.45

Net debt / equity

0.39

Piotroski F-Score

Property, plant and equipment

$166.2M

Shareholders' equity

$785.7M

Tangible book value

$-9.5M

Tangible book value per share

$-0.07

Total assets

$1.4B

Total cash

$145.5M

Total debt

$448.4M

Total liabilities

$566.5M

WACC

11.85%

Metric	Value
Asset turnover	0.56
Current assets	$381.5M
Current liabilities	$105.9M
Current ratio	3.6
Inventory turnover	14.02
Net working capital	$135.5M
Quick ratio	3.04
Working capital	$275.6M
Working capital turnover	2.7

Metric

Value

Asset turnover

0.56

Current assets

$381.5M

Current liabilities

$105.9M

Current ratio

3.6

Inventory turnover

14.02

Net working capital

$135.5M

Quick ratio

3.04

Working capital

$275.6M

Working capital turnover

2.7

Metric	Value
Buyback yield / dilution	-1.26%
Dividend yield	0%
Shareholder yield	-1.26%

Metric

Value

Buyback yield / dilution

-1.26%

Dividend yield

Shareholder yield

-1.26%

Metric	Value
10Y price change	118.36%
10Y return CAGR	8.12%
10Y total return	118.36%
150-day SMA	$13.48
15Y price change	1,282.95%
15Y return CAGR	19.14%
15Y total return	1,282.95%
1D price change	4.11%
1M price change	-7.71%
1M total return	-7.71%
1W price change	7.34%
1W total return	7.34%
1Y price change	75.59%
1Y return CAGR	75.66%
1Y total return	75.59%
20-day SMA	$16.94
200-day SMA	$12.74
20Y price change	1,221.48%
20Y return CAGR	13.78%
20Y total return	1,221.48%
3M price change	35.77%
3M total return	35.77%
3Y price change	31.08%
3Y return CAGR	9.44%
3Y total return	31.08%
50-day SMA	$17.64
50-day SMA vs 200-day SMA	50over200
52-week high	$20.15
52-week high date	2026-10-06
52-week low	$7.07
52-week low date	2026-03-30
5Y price change	-59.87%
5Y return CAGR	-16.69%
5Y total return	-59.87%
6M price change	107.2%
6M total return	107.2%
After-hours change	-1.56%
After-hours close	$17.27
After-hours price	$17.00
All-time high	$61.57
All-time high date	2021-02-16
All-time low	$0.04
All-time low date	2003-04-16
Average true range (ATR)	$0.84
Average volume	2.1M
Beta (1Y)	0.64
Beta (2Y)	1.16
Beta (5Y)	1.78
Change from 52-week high	-10.77%
Change from 52-week low	154.49%
Change from all-time high	-71.02%
Change from all-time low	44,500%
Change from open	3.93%
Day's gap	0.17%
Dollar volume	$34.3M
High price	$17.99
Low price	$17.25
Monthly RSI	60.27
Open price	$17.30
Position in 52-week range	98.65%
Premarket change	-0.81%
Premarket close	$17.27
Premarket price	$17.13
Premarket volume	20.1K
Previous close	$17.27
Price vs 150-day SMA	32.3%
Price vs 20-day SMA	5.34%
Price vs 200-day SMA	40.08%
Price vs 50-day SMA	1.15%
Relative volume	0.9
RSI	55.52
Sharpe ratio	1.25
Sharpe ratio (3Y)	0.4
Sharpe ratio (5Y)	0.04
Sortino ratio	2.05
Sortino ratio (3Y)	0.66
Sortino ratio (5Y)	0.14
Volume	1.9M
Weekly RSI	61.92
YTD price change	51.7%
YTD total return	51.7%

Metric

Value

10Y price change

118.36%

10Y return CAGR

8.12%

10Y total return

118.36%

150-day SMA

$13.48

15Y price change

1,282.95%

15Y return CAGR

19.14%

15Y total return

1,282.95%

1D price change

4.11%

1M price change

-7.71%

1M total return

-7.71%

1W price change

7.34%

1W total return

7.34%

1Y price change

75.59%

1Y return CAGR

75.66%

1Y total return

75.59%

20-day SMA

$16.94

200-day SMA

$12.74

20Y price change

1,221.48%

20Y return CAGR

13.78%

20Y total return

1,221.48%

3M price change

35.77%

3M total return

35.77%

3Y price change

31.08%

3Y return CAGR

9.44%

3Y total return

31.08%

50-day SMA

$17.64

50-day SMA vs 200-day SMA

50over200

52-week high

$20.15

52-week high date

2026-10-06

52-week low

$7.07

52-week low date

2026-03-30

5Y price change

-59.87%

5Y return CAGR

-16.69%

5Y total return

-59.87%

6M price change

107.2%

6M total return

107.2%

After-hours change

-1.56%

After-hours close

$17.27

After-hours price

$17.00

All-time high

$61.57

All-time high date

2021-02-16

All-time low

$0.04

All-time low date

2003-04-16

Average true range (ATR)

$0.84

Average volume

2.1M

Beta (1Y)

0.64

Beta (2Y)

1.16

Beta (5Y)

1.78

Change from 52-week high

-10.77%

Change from 52-week low

154.49%

Change from all-time high

-71.02%

Change from all-time low

44,500%

Change from open

3.93%

Day's gap

0.17%

Dollar volume

$34.3M

High price

$17.99

Low price

$17.25

Monthly RSI

60.27

Open price

$17.30

Position in 52-week range

98.65%

Premarket change

-0.81%

Premarket close

$17.27

Premarket price

$17.13

Premarket volume

20.1K

Previous close

$17.27

Price vs 150-day SMA

32.3%

Price vs 20-day SMA

5.34%

Price vs 200-day SMA

40.08%

Price vs 50-day SMA

1.15%

Relative volume

0.9

RSI

55.52

Sharpe ratio

1.25

Sharpe ratio (3Y)

0.4

Sharpe ratio (5Y)

0.04

Sortino ratio

2.05

Sortino ratio (3Y)

0.66

Sortino ratio (5Y)

0.14

Volume

1.9M

Weekly RSI

61.92

YTD price change

51.7%

YTD total return

51.7%

Metric	Value
Float	117M
Float percentage	91.08%
Shares change (QoQ)	1.29%
Shares change (YoY)	1.26%
Shares held by insiders	2.15%
Shares held by institutions	107.72%
Shares outstanding	128.5M
Short % of float	12.15%
Short % of shares	11.06%
Short ratio	7 days

Metric

Value

Float

117M

Float percentage

91.08%

Shares change (QoQ)

1.29%

Shares change (YoY)

1.26%

Shares held by insiders

2.15%

Shares held by institutions

107.72%

Shares outstanding

128.5M

Short % of float

12.15%

Short % of shares

11.06%

Short ratio

7 days

NeoGenomics, Inc. (NEO)

Price

Financial snapshot

Fair-value bridge

Latest news · NEO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NEO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NEO

Frequently asked questions